Cargando…

Trypsin inhibitors: promising candidate satietogenic proteins as complementary treatment for obesity and metabolic disorders?

The increase in non-communicable chronic diseases has aroused interest in the research of adjuvants to the classic forms of treatments. Obesity and metabolic syndrome are the main targets of confrontation because they relate directly to other chronic diseases. In this context, trypsin inhibitors, mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Cristina Oliveira de Lima, Vanessa, Piuvezam, Grasiela, Leal Lima Maciel, Bruna, Heloneida de Araújo Morais, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327991/
https://www.ncbi.nlm.nih.gov/pubmed/30734596
http://dx.doi.org/10.1080/14756366.2018.1542387